Together, these data support the concept that specific ALS-related mutations in TDP-43 manifest disease by promoting aggregation, whereas the ALS-related FUS mutations work by disruption of nuclear localization of FUS. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.